Stock Events

Stock Events

AIDA Pharmaceuticals 

$0.000300
3
+$0.00+0% Thursday 20:00

Statistics

Day High
0.0002
Day Low
0.0002
52W High
0.0003
52W Low
0.0002
Volume
2,000
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30SepExpected
Q4 2006
Q1 2007
Q2 2007
Q3 2007
Q4 2007
Q1 2008
Q2 2008
-0.25
-0.14
-0.02
0.09
Expected EPS
N/A
Actual EPS
0.0848

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap137.76B
Pfizer is a major player in the pharmaceutical industry, directly competing in multiple therapeutic areas with AIDA.
Merck
MRK
Mkt Cap305.12B
Merck operates globally in various pharmaceutical sectors, often overlapping with AIDA's product lines and research areas.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson offers a wide range of pharmaceutical products that compete with AIDA's offerings, particularly in the areas of immunology and oncology.
GSK
GSK
Mkt Cap105.71B
GlaxoSmithKline competes with AIDA in several key areas, including respiratory and infectious disease treatments.
Novartis
NVS
Mkt Cap293.94B
Novartis competes with AIDA in multiple segments such as cardiovascular, oncology, and neurology drugs.
Abbvie
ABBV
Mkt Cap438.31B
AbbVie has a strong presence in biopharmaceuticals, directly competing with AIDA in areas like immunology and oncology.
Bristol-Myers Squibb
BMY
Mkt Cap117.58B
Bristol-Myers Squibb's extensive range of cancer and immunology drugs places it in direct competition with AIDA.
Sanofi
SNY
Mkt Cap104.13B
Sanofi operates globally in pharmaceuticals, competing with AIDA especially in diabetes and cardiovascular drugs.
Lilly(Eli) &
LLY
Mkt Cap1.06T
Eli Lilly and Company's focus on diabetes, cancer, and autoimmune diseases makes it a significant competitor to AIDA.
Astrazeneca
AZN
Mkt Cap266.15B
AstraZeneca has a strong portfolio in areas like oncology, cardiovascular, and respiratory diseases, competing with AIDA's products.

About

Aida Pharmaceuticals, Inc., together with its affiliates, operates extensively throughout mainland China, specializing in the entire spectrum of pharmaceutical and genetic product development. This encompasses formulation, clinical trials, regulatory registration, manufacturing, sales, and marketing. The company's diverse product range includes antibiotics, cardiovascular medicines, and anti-cancer drugs. These are available in various forms, such as injectable powders, intravenous liquids, capsules, tablets, and ointments. Notable products feature Etimicin Sulfate, provided as an injectable powder, and rh-Apo2l, a biopharmaceutical therapy targeting cancers. Established in 1999, Aida Pharmaceuticals, Inc. is headquartered in Hangzhou, China.
Show more...
CEO
Mr. Biao Jin
Employees
450
Country
United States
ISIN
US0087211027

Listings

OTC Link
US
AIDA

0 Comments

Share your thoughts

FAQ

What is AIDA Pharmaceuticals stock price today?▼
The current price of AIDA is $0.00 USD — it has increased by +0% in the past 24 hours. Watch AIDA Pharmaceuticals stock price performance more closely on the chart.
What is AIDA Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange AIDA Pharmaceuticals stocks are traded under the ticker AIDA.
What were AIDA Pharmaceuticals earnings last quarter?▼
AIDA earnings for the last quarter are 0.08 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does AIDA Pharmaceuticals have?▼
As of July 18, 2026, the company has 450 employees.
In which sector is AIDA Pharmaceuticals located?▼
AIDA Pharmaceuticals operates in the Health & Wellness sector.
When did AIDA Pharmaceuticals complete a stock split?▼
The last stock split for AIDA Pharmaceuticals was on January 22, 2004 with a ratio of 1:800.
Where is AIDA Pharmaceuticals headquartered?▼
AIDA Pharmaceuticals is headquartered in Hangzhou, United States.